BioCentury | Jan 8, 2021
Emerging Company Profile
Co-founded by Mukherjee and Vale, Myeloid is directing monocytes against cancer
Myeloid is engineering monocytes as cellular cancer therapies by programming pluripotent myeloid cells to target tumor cells and conduct a suite of myeloid antitumor functions. Ronald Vale and Siddhartha Mukherjee are among the founders of...